Press "esc" to clear
Go to Advanced Search

Showing results

110 of 2930

Article ID: 705504

Research suggests path to vaccine or drug for late-onset Alzheimer’s

UT Southwestern Medical Center

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

14-Dec-2018 2:05 PM EST

Article ID: 705497

DOE approves technical plan and cost estimate to upgrade Argonne facility; Project will create X-rays that illuminate the atomic scale, in 3D

Argonne National Laboratory

The U.S. Department of Energy has approved the technical scope, cost estimate and plan of work for an upgrade of the Advanced Photon Source, a major storage-ring X-ray source at Argonne.

14-Dec-2018 12:05 PM EST

Article ID: 705422

Cancer patients face higher risk for shingles, new vaccines hold promise for prevention

Infectious Diseases Society of America (IDSA)

People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according to a new study in the Journal of Infectious Diseases. The findings may help guide efforts to prevent the often painful skin condition in cancer patients through the use of new vaccines. The large prospective study expands on previous research by examining the risk of shingles before and after a new cancer diagnosis and across a range of cancer types among approximately 240,000 adults in Australia from 2006 to 2015.

13-Dec-2018 12:05 PM EST

Article ID: 705392

New Study Investigates Treatments for Prurigo Nodularis

George Washington University

A team from the GW School of Medicine and Health Sciences found emerging treatments, such as neurokinin-1 receptor antagonists, were the most promising against prurigo nodularis.

13-Dec-2018 9:00 AM EST

Article ID: 705373

Blood Test Could Lead to Cystic Fibrosis Treatment Tailored to Each Patient

Ann and Robert H. Lurie Children's Hospital of Chicago

Researchers at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient’s precise biology.

12-Dec-2018 4:05 PM EST

Article ID: 705336

What can a snowflake teach us about how cancer spreads in the body?

University of Southern California Viterbi School of Engineering

Conventional math cannot adequately model the interaction of multiple genes over multiple time frames – a necessary foundation for any cancer-fighting drugs. The study, published in “Frontiers in Physiology” by Mahboobeh Ghorbani, Edmond Jonckheere and Paul Bogdan of the Ming Hsieh Department of Electrical Engineering, is the first study that accounts for the memory, cross-dependence and fractality of gene expression

12-Dec-2018 12:05 PM EST
  • Embargo expired:
    12-Dec-2018 12:00 PM EST

Article ID: 705198

Five things anyone can do to prevent addiction or help people suffering

University of Alabama at Birmingham

While friends or family members may feel helpless if someone they know suffers from addiction, one UAB physician says hope can start at home.

10-Dec-2018 3:00 PM EST

Social and Behavioral Sciences


Article ID: 705327

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

La Jolla Institute for Immunology

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and easily find the best clinicians or pioneering scientists specializing in a wide range of medical conditions or biomedical topics.

12-Dec-2018 11:05 AM EST

Article ID: 705271

Lowest-Priced Generic Drugs More Likely to Experience Shortages

ISPOR—The Professional Society for Health Economics and Outcomes Research

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that the lowest priced generic drugs are at a substantially elevated risk of experiencing a drug shortage, and that periods of drug shortages are associated with only modest increases in drug prices.

12-Dec-2018 8:05 AM EST

Showing results

110 of 2930

Chat now!